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Introduction
Blood cell development in Drosophila has been shown to
employ several genetic mechanisms with similarities to those
that operate during vertebrate hematopoiesis (reviewed by
Evans et al., 2003). Likewise, significant similarities exist
between vertebrates and Drosophila in the early developmental
strategies employed when vascular and hematopoietic
components separate within the cardiogenic mesoderm
(Mandal et al., 2004). Drosophila is also well established as a
model of innate immunity, particularly the mechanisms and
pathways regulating humoral immune responses (Brennan
and Anderson, 2004; Hoffmann, 2003; Hultmark, 1993).
Circulating Drosophila blood cells (hemocytes) have been
shown to act as sentinels by monitoring the environment and
initiating humoral immune responses via a cytokine-like
signaling mechanism (Agaisse et al., 2003). These hemocytes
also provide cellular immunity by removing microbial
pathogens via phagocytosis and through the encapsulation and
melanization of larger parasitic pathogens (Lavine and Strand,
2002; Meister, 2004).
In Drosophila, mature hemocytes arise from two spatially
and temporally distinct phases of hematopoietic development,
one early in the embryonic head mesoderm and another at later
larval stages in a specialized organ called the lymph gland
(Lebestky et al., 2000; Rizki, 1978; Tepass et al., 1994). The
embryonic phase of hematopoiesis gives rise to mature,
circulating hemocytes of the larval stages, whereas lymph
gland hemocytes, under normal, non-immune conditions, do
not enter circulation until the onset of metamorphosis (Holz et
al., 2003). Once in circulation, these lymph gland-derived
hemocytes, along with a subset of hemocytes derived from the
embryonic head mesoderm, can persist into the adult stage
(Holz et al., 2003). The lymph gland originates in the
cardiogenic mesoderm of the embryo and subsequently grows
by cellular proliferation during the larval instars. Although the
function of the lymph gland as a hematopoietic organ is
well established (reviewed by Evans et al., 2003; Lanot et al.,
2001; Shrestha and Gateff, 1982; Sorrentino et al., 2002),
surprisingly little is known about the spatial and temporal
events regulating this process. This paucity of detail is
primarily due to a lack of lineage-specific genetic markers,
which is in sharp contrast to the level of detail afforded to other
Drosophila tissues such as the salivary glands, imaginal discs
and ovaries, not to mention that seen for vertebrate
hematopoietic systems. In this report, we address the
spatiotemporal events of lymph gland hematopoiesis through
an in-depth characterization of known and novel genetic
markers.
In Drosophila, there are at least three terminally
differentiated hemocyte types: plasmatocytes, crystal cells and
lamellocytes (Evans et al., 2003; Rizki, 1956). Each type is
thought to be derived from a common precursor that expresses
and requires the GATA factor Serpent (Srp) (Rehorn et al.,
1996; Tepass et al., 1994). Plasmatocytes represent 90-95%
of all mature Drosophila hemocytes and function in the
phagocytic removal of dead cells and microbial pathogens
(Rizki, 1978; Tepass et al., 1994). The specification of
plasmatocytes requires the transcription factors Glial cells
missing (Gcm) and Gcm2 (Alfonso and Jones, 2002;
Bernardoni et al., 1997). Additionally, circulating
Drosophila hematopoiesis occurs in a specialized organ
called the lymph gland. In this systematic analysis of lymph
gland structure and gene expression, we define the
developmental steps in the maturation of blood cells
(hemocytes) from their precursors. In particular, distinct
zones of hemocyte maturation, signaling and proliferation
in the lymph gland during hematopoietic progression are
described. Different stages of hemocyte development have
been classified according to marker expression and placed
within developmental niches: a medullary zone for
quiescent prohemocytes, a cortical zone for maturing
hemocytes and a zone called the posterior signaling center
for specialized signaling hemocytes. This establishes a
framework for the identification of Drosophila blood cells,
at various stages of maturation, and provides a genetic
basis for spatial and temporal events that govern hemocyte
development. The cellular events identified in this analysis
further establish Drosophila as a model system for
hematopoiesis.
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plasmatocytes have been shown to express Peroxidasin (Pxn)
(Nelson et al., 1994), a component of the extracellular matrix,
and an uncharacterized surface marker called P1 antigen (Asha
et al., 2003; Vilmos et al., 2004). Crystal cells, which constitute
~5% of the hemocyte population, are non-phagocytic cells that
facilitate innate immune and wound-healing responses by
mediating the process of melanization (Lanot et al., 2001;
Rizki, 1978; Russo et al., 1996). Crystal cell differentiation
requires the cell-autonomous expression of the transcription
factor Lozenge, a Runt-domain protein that shares homology
with mammalian Runx proteins, including Acute Myeloid
Leukemia 1 (AML1 or Runx1) (Daga et al., 1996; de Bruijn
and Speck, 2004; Lebestky et al., 2000). Additionally, mature
crystal cells express Prophenoloxidase A1 (ProPOA1), an
oxidoreductase related to hemocyanins and vertebrate
tyrosinases that mediates melanization reactions upon
activation (Rizki and Rizki, 1985; Soderhall and Cerenius,
1998). Lamellocytes are relatively large (15-40 µm across),
flat, adherent cells that primarily function in the encapsulation
and neutralization of objects too large to be engulfed by
plasmatocytes (Rizki and Rizki, 1992). Lamellocytes have not
been found in embryos or adults and are rarely observed during
larval stages, although large numbers of these cells can be
induced to differentiate in larvae upon challenge with parasitic
wasp eggs (Lanot et al., 2001; Sorrentino et al., 2002).
Genetically, mature lamellocytes have commonly been
identified by their expression of a reporter in the misshapen
locus (Braun et al., 1997; Lanot et al., 2001; Sorrentino, 2002),
which encodes a component of the JUN kinase signaling
cascade. Additionally, lamellocytes express an uncharacterized
surface marker called L1 antigen (Asha et al., 2003). All
Drosophila hemocytes specifically express the marker Hemese
(He) (Kurucz et al., 2003), while a majority of plasmatocytes
and crystal cells express the Collagens Viking and Cg25C (Le
Parco et al., 1986; Yasothornsrikul et al., 1997) and the Von
Willebrand-like factor Hemolectin (Hml) (Goto et al., 2003;
Goto et al., 2001; Sinenko and Mathey-Prevot, 2004).
Several signaling pathways have been associated with the
Drosophila hematopoietic process. Hyperactivation of the
JAK homolog Hopscotch (Hop) causes extensive hemocyte
proliferation, lamellocyte differentiation and melanized
pseudotumor formation at high frequency (Harrison et al., 1995;
Hou et al., 2002; Luo et al., 1995). Despite this apparent role in
regulating hemocyte proliferation, hop loss-of-function has no
overt effect upon the numbers of circulating hemocytes or the
growth of the lymph gland (Remillieux-Leschelle et al., 2002;
Sorrentino et al., 2004). Loss of function does, however, impair
the ability of the lymph gland to mount an effective immune
response to parasitization (Sorrentino et al., 2004). In mammals,
JAK/STAT signaling is required for various aspects of
hematopoiesis and immunity and dysregulation of this pathway
has been associated with numerous malignancies including
lymphomas and leukemias (Rane and Reddy, 2002; Ward et al.,
2000). Misregulation of the Drosophila Toll pathway, which
is related to vertebrate NF!B/I!B signaling pathways, also
causes significant hematopoietic defects that include aberrant
proliferation and differentiation (Gerttula et al., 1988; Qiu et al.,
1998). Finally, the receptor tyrosine kinase Pvr, which shares
homology with vertebrate PDGF and VEGF receptors, is known
to function in embryonic hemocytes where it controls migration
and cell survival (Bruckner et al., 2004; Cho et al., 2002; Heino
et al., 2001; Sears et al., 2003). The Pvr pathway may also have
a role in proliferation control because misexpression of the
ligand Pvf2 causes significant expansion of the lymph gland
(Munier et al., 2002). Taken together, it is clear that the
JAK/STAT, Toll and Pvr pathways play significant roles in
Drosophila hematopoiesis.
A considerable amount is known about the role of the Notch
signaling pathway in controlling lymph gland hematopoiesis. In
addition to a role in proliferation, Notch signaling is required for
the early specification of the lymph gland (Mandal et al., 2004)
and the determination of the crystal cell hemocyte lineage, both
in the lymph gland and in the embryonic head mesoderm (Duvic
et al., 2002; Lebestky et al., 2003). Furthermore, the study of
Notch function in hematopoiesis has led to the identification of
the first subdomain or compartment in the lymph gland, which
was termed the posterior signaling center (PSC) (Lebestky et al.,
2003). The PSC consists of a small cluster of cells at the
posterior tip of each of the primary (anterior-most) lymph gland
lobes and is defined by the expression of the Notch ligand Serrate
(Ser). Serrate signaling through Notch mediates the commitment
of prohemocytes to the crystal cell lineage via the expression of
Lozenge. Recently, the transcription factor Collier, which shares
homology with mammalian Early B-cell Factor (EBF), has been
shown to be expressed in the PSC earlier than Ser and to control
Ser expression in these cells (Crozatier et al., 2004). collier
mutant larvae fail to produce lamellocytes, even upon
parasitization, indicating a role of the PSC in both crystal cell
and lamellocyte specification.
In this report, we provide a description of the lymph gland as
a developmental system based on the dynamic expression and
function of a number of known as well as uncharacterized
hematopoietic and pro-hemocytic markers. This molecular
genetic and structural analysis reveals novel features and
provides a comprehensive picture of, and a mechanistic basis for,
the spatial and temporal events that give rise to blood cells from
their precursors within the lymph gland.
Materials and methods
Drosophila strains and crosses
The following Drosophila strains were used in the described
experiments: odd-lacZ (J. Lengyel); GFP-trap lines ZCL0611,
ZCL2375, ZCL2826, ZCL2856, ZCL2867 and ZCL2897 (L. Cooley);
G147 and G454 (X. Morin); Cg-gal4 (C. Dearolf); dome-gal4 (S.
Noselli); upd3-gal4 (N. Perrimon); Dot-gal4 (D. Kimbrell); Ser-lacZ
(E. Knust); hml"-gal4, UAS-GFP (S. Sinenko); Pvrc2195 FRT40A/CyO
(Exelixis, D. Montell); and Ser-gal4. A 9.5 kb enhancer region of
Serrate (Bachmann and Knust, 1998) was used to generate Ser-gal4
transgenic flies (Joyce Stamm and U.B., unpublished). The following
stocks were obtained from the Bloomington Stock Center: hml-gal4;
UAS-GFP, msn06946/TM3 (msn-lacZ), w*; In(2LR) noc4L Scorv9R
b1/CyO, P{w[+mC]=ActGFP}JMR1, hsFLP and Ubi-GFP FRT40A,
twist-gal4, P{ry[+t7.2]=Act5C(FRT.polyA)lacZ.nls1}3 ry[506], y[1]
w[*]; P{UAS-FLP1.D}JD1. Oregon R was used for wild type. To
generate somatic clones, hsFLP; Pvrc2195 FRT40A/Ubi-GFP, FRT40A
larvae were heat-shocked at 37°C for 1 hour at the first instar.
Immunohistochemistry
Lymph glands were stained as previously described (Lebestky et al.,
2000). The following antibodies were used in the described
experiments: rabbit #-Srp (D. Hoshizaki), rabbit #-$gal (Cappell),
mouse #-$gal (Promega), mouse #-Lz, mouse #-Pxn (J. Fessler and L.
Fessler), mouse #-Hemese, mouse #-P1 and mouse #-L1 (I. Ando),
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mouse #-Cut (Developmental Studies Hybridoma Bank), rat #-DE-
cadherin (V. Hartenstein), rabbit #-U-shaped (R. Schulz), rat #-Pvr (B.
Shilo and P. Garrity) and rat #-ProPO (H. Müller). Alexa Fluor 488-,
Alexa Fluor 546- (Molecular Probes) and Cy3- (Jackson Laboratory)
conjugated secondary antibodies were used. Lymph glands were
mounted in Vectashield (Vector Laboratories) alone or Vectashield with
To-Pro-3 (Molecular Probes) for nuclear staining. Unless otherwise
stated, late third instar larvae were used. For second instar lymph gland
staining, first instar larvae were collected upon hatching at 1 hour
intervals, maintained at 25°C, and dissected between 40 and 44 hours
post-hatching.
BrdU analysis
Dissected lymph glands were incubated in the 75 µg/ml BrdU in PBS
for 1 hour, fixed immediately in 4% formaldehyde/PBS for 30 minutes,
washed three times for 10 minutes each in PBS, blocked in 10% normal
goat serum/PBS, then incubated in mouse #-GFP antibody (Molecular
Probes) or #-Pxn overnight. Lymph glands were washed four times in
PBS, fixed again in 2% formaldehyde/PBS for 15 minutes, washed three
times for 5 minutes, and then incubated in 2 M HCl for 30 minutes to
denature BrdU-labeled DNA. Lymph glands were then washed four
times for 10 minutes each and stained with rat #-BrdU (Abcam)
antibody, followed by standard secondary antibody staining and
mounting.
Results
Gross structure of the larval lymph gland
In the late embryo, the lymph gland consists of a single pair of
lobes containing ~20 cells each. These express the transcription
factors Srp and Odd skipped (Odd) (Fig. 1A,B), and each
cluster of hemocyte precursors is followed by a string of Odd-
expressing pericardial cells that are proposed to have
nephrocyte function. These lymph gland lobes are arranged
bilaterally such that they flank the dorsal vessel, the simple
aorta/heart tube of the open circulatory system, at the midline
(Fig. 1B). By the second larval instar, lymph gland morphology
is distinctly different in that two or three new pairs of posterior
lobes have formed and the primary lobes have increased in size
approximately tenfold (to ~200 cells, Fig. 1C,D). By the late
third instar, the lymph gland has grown significantly in size
(approximately another tenfold) but the arrangement of the
lobes and pericardial cells has remained the same. The cells of
the third instar lymph gland continue to express Srp (Fig. 1E)
and Odd (not shown).
The third instar lymph gland also exhibits a strong,
branching network of extracellular matrix (ECM) throughout
the primary lobe (Fig. 1F,G). This network was visualized
using several GFP-trap lines in which GFP is fused to
endogenous proteins (Kelso et al., 2004; Morin et al., 2001).
For example, line G454 represents an insertion into the viking
locus, which encodes a Collagen IV component of the
extracellular matrix (Yasothornsrikul et al., 1997). The
hemocytes in the primary lobes of G454 (expressing Viking-
GFP) appear to be clustered into small populations within
pockets or chambers bounded by GFP-labeled branches of
Fig. 1. Morphological features of the developing lymph
gland. (A,B) Lymph glands at embryonic stage 16.
Cells of the embryonic lymph gland (shown in whole
mount) express the hemocyte marker Srp (A, red) and
Odd (odd-lacZ expression in B, green; the bluish-green
appearance is due to overlap with nuclear marker To-
pro-3 in blue). Pericardial cells (B, arrowhead), also
express Odd. Cells between the two symmetric lymph
gland clusters represent dorsal vessel (DV) cells (B).
Scale bar: 10 µm. (C,D) Second instar larval lymph
gland. Expression of Srp (C) and odd-lacZ (D) is
maintained in the second instar. By this stage, the
lymph gland consists of a pair of primary (1°) lobes
and smaller, posterior secondary (2°) lobes separated
by pericardial cells (arrowhead in D). Scale bar: 10 µm.
Expression of odd-lacZ is slightly higher in the region
of the posterior signaling center (PSC) of the primary
lobes. (E) Multi-lobed structure of the third instar
lymph gland. Srp (red) is ubiquitously expressed.
Pericardial cells separate lymph gland lobes as in the
second instar. Scale bar: 100 µm. (F,G) Expression
pattern of Viking-GFP fusion protein (F, green) reveals
chamber-like structures within the lymph gland.
Similar structures are seen in lymph glands of the
uncharacterized GFP-trap line ZCL2867 (G, green).
Scale bar: 10 µm. To-pro-3 (blue) shows nuclei.
(H,I) Morphological features of the third instar lymph
gland. (H) A DIC image of the third instar lymph gland
shows two distinct regions within the primary lobe that
we call the cortical zone (CZ) and the medullary zone
(MZ) (see text for details). Arrows indicate the
boundary between the zones. The secondary (2°) lobe
is similar in appearance to the medullary zone. (I) Confocal section through a lymph gland from the GFP-trap line G147. Cells in the medullary









various sizes (Fig. 1F). Other lines, such as the uncharacterized
GFP-trap line ZCL2867 (Fig. 1G), also highlight this branching
pattern. What role this intricate ECM network plays in
hematopoiesis, as well as why multiple cells cluster within
these ECM chambers, remains to be determined.
Careful examination of dissected, late third-instar lymph
glands by differential interference contrast (DIC) microscopy
revealed the presence of two structurally distinct regions within
the primary lymph gland lobes that have not been previously
described (Fig. 1H). The periphery of the primary lobe
generally exhibits a granular appearance, whereas the medial
region looks smooth and compact. These characteristics were
examined further with confocal microscopy using a GFP-trap
line G147, in which GFP is fused to a microtubule-associated
protein (Morin et al., 2001). The G147 line is expressed
throughout the lymph gland but, in contrast to nuclear markers
such as Srp and Odd, distinguishes morphological differences
among cells because the GFP-fusion protein is expressed in the
cytoplasm in association with the microtubule network (Fig.
1I). Cells in the periphery of the lymph gland make relatively
few cell-cell contacts, thereby giving rise to gaps and
voids among the cells within this region. This cellular
individualization is consistent with the granularity of the
peripheral region observed by DIC microscopy (Fig. 1H). By
contrast, cells in the medial region were relatively compact
with minimal intercellular space, which is also consistent with
the smoother appearance of this region by DIC microscopy.
Thus, in the late third instar, the lymph gland primary lobes
consist of two physically distinct regions: a medial region
consisting of compactly arranged cells, which we term the
medullary zone; and a peripheral region of loosely arranged
cells that we term the cortical zone (Fig. 1H,I).
Maturing hemocytes are restricted to the cortical
zone of primary lymph gland lobes
Mature hemocytes have been shown to express several
markers, including collagens (Asha et al., 2003; Fessler et al.,
1994; Yasothornsrikul et al., 1997), Hemolectin (Goto et al.,
2003; Goto et al., 2001), Lozenge (Lebestky et al., 2000),
Peroxidasin (Nelson et al., 1994) and P1 antigen (Asha et al.,
2003; Vilmos et al., 2004). We found that the expression of the
reporter Collagen-gal4 (Cg-gal4) (Asha et al., 2003), which is
expressed by both plasmatocytes and crystal cells, is restricted
to the periphery of the primary lymph gland lobe (Fig. 2A).
Comparison of Cg-gal4 expression in G147 lymph glands,
in which the medullary zone and cortical zone can be
distinguished, revealed that maturing hemocytes are restricted
to the cortical zone (Fig. 2B,B%). In fact, the expression of each
of the maturation markers mentioned above is found to be
restricted to the cortical zone. The reporter hml-gal4 (Goto et
al., 2003) and Pxn, which are expressed by the plasmatocyte
and crystal cell lineages, are extensively expressed in this
region (Fig. 2C,D). Likewise, the expression of the crystal cell
lineage marker Lozenge is restricted in this manner (Fig. 2E).
The spatial restriction of maturing crystal cells to the cortical
zone was verified by several means, including the distribution
of melanized lymph gland crystal cells in the Black cells
background (Fig. 2F) and analysis of the terminal marker
ProPOA1 (not shown). The cortical zone is also the site of P1
antigen expression (Fig. 2G), a marker of the plasmatocyte
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Fig. 2. Maturing hemocytes are
found in the cortical zone. (A) Cg-
gal4/UAS-GFP-expressing cells
(green) are found in the periphery
of the primary lobe.
(B,B%) Flattened confocal image
of a third instar G147 lymph
gland. GFP expression (green)
identifies the cortical and
medullary zones. Cg-gal4/UAS-
lacZ (B%, red) expression is
restricted to the cortical zone (CZ)
and is excluded from the
medullary zone (MZ).
(C-G) Mature hemocyte markers
are restricted to the cortical zone.
Hemocyte markers hml-gal4/UAS-
GFP (C, green) and Pxn (D, red),
crystal cell markers Lz (E; red)
and Black cells (Bc, F), and
plasmatocyte marker P1 (G, red)
are limited to the cortical zone.
(H,I) The uncharacterized GFP-
trap line ZCL2826 (H, green) and
the transcription factor Cut (I, red)
are preferentially expressed in the
cortical zone. (J,K) Lamellocytes,
when present, are found in the
cortical zone. Lamellocytes can be distinguished by morphology in G147 background (J,K, green, arrows) and by co-localization with msn-lacZ
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lineage. The uncharacterized GFP fusion line ZCL2826 also
exhibits preferential expression in the cortical zone (Fig. 2H).
Last, we found that the homeobox transcription factor Cut
(Blochlinger et al., 1993) is preferentially expressed in the
cortical zone of the primary lobe (Fig. 2I). Although the role
of Cut in Drosophila hematopoiesis is currently unknown,
homologs of Cut are known to be regulators of the myeloid
hematopoietic lineage in both mice and humans (Bjerregaard
et al., 2003; Sinclair et al., 2001). Cells of the rare third cell
type, lamellocytes, are also restricted to the cortical zone (Fig.
2J,K), based upon cell morphology and the expression of a
msn-lacZ reporter (msn06946). In summary, based on the
expression patterns of several genetic markers that identify the
three major blood cell lineages, we propose that the cortical
zone is a specific site for hemocyte maturation.
Differential gene expression in the medullary zone
The medullary zone was initially defined by structural
characteristics (Fig. 1H,I) and subsequently by the lack of
expression of mature hemocyte markers (Fig. 2). However, we
have also identified several markers that are exclusively
expressed in the medullary zone at high levels but not the
cortical zone. Consistent with the compact arrangement of cells
in the medullary zone, we found that Drosophila E-cadherin
(DE-cadherin or Shotgun) is highly expressed in this region
(Fig. 3A). No significant expression of DE-cadherin was
observed among maturing cells in the cortical zone. E-
cadherin, in both vertebrates and Drosophila, is a Ca2+-
dependent, homotypic adhesion molecule often expressed by
epithelial cells and is a crucial component of adherens
junctions (Perez-Moreno et al., 2003). Attempts to study DE-
cadherin mutant clones in the medullary zone where the
protein is expressed were unsuccessful as no clones were
recoverable. We also found that the reporter lines domeless-
gal4 (Bourbon et al., 2002) and unpaired3-gal4 (Agaisse et al.,
2003) are preferentially expressed in the medullary zone (Fig.
3B,C). The gene domeless (dome) encodes a receptor molecule
known to mediate the activation of the JAK/STAT pathway
upon binding of the ligand Unpaired (Brown et al., 2001; Chen
et al., 2002). The unpaired3 (upd3) gene encodes a protein with
homology to Unpaired and has been associated with innate
immune function (Agaisse et al., 2003). These gal4 lines are
used here only as markers that correlate with the medullary
zone and, at the present time, we have no evidence that their
associated proteins have a role in lymph gland hematopoiesis.
Other markers of interest with preferential expression in the
Fig. 3. Expression profile of the medullary zone and the PSC. (A-E) Marker expression in the medullary zone. Medullary zone cells are
characterized by their expression of DE-cadherin (A, red), dome-gal4/UAS-GFP (B, green), upd3-gal4/UAS-GFP (C, green), the
uncharacterized GFP fusion line ZCL2897 (D, green), and act5C-GFP (E, green). The cortical zone is marked by Lz staining (A, green; C, red)
as well as by P1-antigen staining (E, red). (F-J) Markers expressed in the posterior signaling center (PSC) cells. PSC cells are marked by Ser-
lacZ (F-I, red) and show high levels of expression of Dorothy-gal4/UAS-GFP (F, green), upd3-gal4/UAS-GFP (G, green), uncharacterized GFP-
trap lines ZCL2375 (H, green), ZCL2856 (I, green) and ZCL0611 (J, green). In H and I, insets show only the GFP expression in the PSC regions
indicated by the arrows. upd3-gal4/UAS-GFP (G) is expressed in only a subset of PSC cells. PC, pericardial cell. (K-O) Lack of expression of
specific markers also defines the PSC. PSC cells are positively marked by Ser-lacZ (red) and characterized by absence of expression of Pvr (K,
green; inset shows the PSC region without Ser-lacZ for clarity), dome-gal4/UAS-GFP (L, green), Cg-gal4/UAS-GFP (M, green), U-shaped (N,









medullary zone include the molecularly uncharacterized GFP-
trap line ZCL2897 (Fig. 3D) and actin5C-GFP (Fig. 3E). Cells
expressing hemocyte maturation markers are not seen in the
medullary zone. It is therefore reasonable to propose that this
zone is largely populated by prohemocytes that will later
mature in the cortical zone. Prohemocytes are characterized by
their lack of maturation markers, as well as their expression of
several markers described in this section.
The PSC represents a distinct lymph gland zone
The PSC is defined by its expression of the Notch ligand
Serrate (Lebestky et al., 2003) and the transcription factor
Collier (Crozatier et al., 2004). During our analysis, several
additional markers were identified that exhibit specific or
preferential expression in the PSC region. For example, we
found that the reporter Dorothy-gal4 (Kimbrell et al., 2002) is
strongly expressed in this zone (Fig. 3F). The Dorothy gene
encodes a UDP-glycosyltransferase (Zhou et al., 2001), which
belongs to a class of enzymes that function in the detoxification
of metabolites. The upd3-gal4 reporter, which has preferential
expression in the medullary zone, is also strongly expressed
among cells of the PSC (Fig. 3G). Last, we found three
uncharacterized GFP-gene trap lines, ZCL2375, ZCL2856 and
ZCL0611 (Kelso et al., 2004), which are preferentially
expressed in the PSC (Fig. 3H-J). This analysis has made it
clear that the PSC is a distinct zone of cells that can be defined
by the expression of multiple gene products.
We have also found that the PSC can be defined just as
definitively by the characteristic absence of several markers.
For example, the RTK receptor Pvr, which is expressed
throughout the lymph gland, is notably absent from the PSC
(Fig. 3K). Likewise, dome-gal4 is not expressed in the PSC
(Fig. 3L), further suggesting that this population of cells is
biased toward the production of ligands rather than receptor
proteins. Maturation markers such as Cg-gal4, which are
expressed throughout the cortical zone, were never found to be
expressed by PSC cells (Fig. 3M). Additionally, we found that
the expression levels of the hemocyte marker Hemese (Kurucz
et al., 2003) and the Friend-of-GATA protein U-shaped
(Fossett et al., 2001) are dramatically reduced in the PSC when
compared with other hemocytes of the lymph gland (Fig.
3N,O). Taken together, both the expression and lack of
expression of a number of genetic markers defines the cells of
the PSC as a unique hemocyte population.
Hematopoietic differentiation in secondary lymph
gland lobes
In contrast to primary lobes of the third instar, maturing
hemocytes are generally not seen in the secondary lobes.
Correspondingly, secondary lobes often have a smooth and
compact appearance (Fig. 1H), much like the medullary zone
of the primary lobe. Consistent with this appearance, secondary
lymph gland lobes also express high levels of DE-cadherin
(Fig. 4A). The size of the secondary lobe, however, varies from
animal to animal and this correlates with the presence or
absence of maturation markers. Smaller secondary lobes
contain a few or no cells expressing maturation markers,
whereas larger secondary lobes usually exhibit groups of
differentiating cells. Direct comparison of DE-cadherin
expression in secondary lobes with that of Cg-gal4, hml-gal4
or Lz revealed that the expression of these maturation markers
occurs only in areas in which DE-cadherin is downregulated
(Fig. 4B-E%). Therefore, although there is no apparent
distinction between cortical and medullary zones in
differentiating secondary lobes, there is a significant
correlation between the expression of maturation markers and
the downregulation of DE-cadherin, as is observed in primary
lobes.
Temporal analysis of lymph gland hematopoietic
development
The relatively late ‘snapshot’ of lymph gland development in
the third larval instar establishes the existence of spatial zones
within the lymph gland that are characterized by differences in
structure as well as gene expression (Fig. 4F). In order to
understand how these zones form over time, lymph glands of
second instar larvae, the earliest time at which we are able to
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Fig. 4. Hemocyte development in the secondary lymph gland lobe of
third instar larva. (A) The secondary lobe expresses high levels of
DE-cadherin (red). (B-E%) Hemocyte formation in larger secondary
lobes. Cg-gal4/UAS-GFP (B,E%, green), hml-gal4/UAS-GFP (C,
green) and Lz (D, green) are seen in patches where DE-cadherin (B-
E%, red) expression is downregulated. This is particularly apparent in
high-magnification images (compare E with E%). To-pro-3 (blue)
marks nuclei. (F) Schematic diagram of the 3rd instar lymph gland
based on our analysis of morphology and hemocyte markers. The
lymph gland flanks the dorsal vessel (DV) and each lobe is separated
by pericardial cells (PC). The primary (1°) lobe consists of three
distinct zones: (1) the cortical zone (CZ), where maturing hemocytes
are found; (2) the medullary zone (MZ), with prohemocytes lacking
differentiation markers; and (3) the posterior signaling center (PSC),
which is a unique population of specialized hemocytes. Secondary
(2°) lobes usually contain immature hemocytes except in random
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Fig. 5. Temporal analysis of hemocyte
maturation. (A) Hemese (He, red) is
expressed by all hemocytes in the
primary lymph gland of the second
instar larva. (B,C) Maturation marker
expression in second instar lymph
glands. (B) Expression of Pxn (red)
and hml"-gal4/UAS-GFP (green)
commence at approximately the same
time during development. Although
most cells express both markers
(yellow), some express only hml"-
gal4/UAS-GFP (arrowhead), and
others express only Pxn (arrow).
(C) Cg-gal4/UAS-GFP (green) is
expressed in a small subset of cells
expressing Pxn (red). (D) P1 antigen
(red) is first expressed in the early third
instar lymph gland. Fewer cells are
seen expressing P1-antigen than Cg-
gal4/UAS-GFP (green). (E) Schematic
representation of the order of
appearance of plasmatocyte maturation
markers. (F-G) Maturing hemocytes,
prohemocytes and pre-prohemocytes
in the second instar lymph gland. (F,F%)
Maturing hemocytes are marked by
Pxn expression (F%, red). These cells
either express low levels of dome-
gal4/UAS-GFP (green, white
arrowheads) or no dome-gal4/UAS-
GFP (yellow arrowheads).
Prohemocytes do not express Pxn, but
are marked by dome-gal4/UAS-GFP
(F,F%, arrows). Finally, pre-
prohemocytes are located medially,
close to the dorsal vessel (DV) and are
characterized by the absence of both
dome-gal4/UAS-GFP and Pxn
expression (asterisks, blue only).
These pre-prohemocytes do express
Hemese (G; red, arrows). (H-K%) The
second instar PSC (arrows) are marked
by Ser-lacZ (H,J,K%; red). Expression
of upd3-gal4/UAS-GFP (I,J, green;
RG, ring gland) initiates in the PSC (I,
arrows) and expands later to other cells
of the lymph gland (J, green). dome-
gal4/UAS-GFP (H, green) and Pvr
(K,K%; green) are not expressed in the
PSC. (L-O) Gal4-based cell-lineage
tracing in the larval lymph gland.
(L) Schematic diagram of the cell-
lineage marking system. Test stock
flies of the genotype UAS-FLP,
actin5C-FRT-STOP-FRT-lacZ is
crossed to various Gal4-expressing
lines (enhancer-gal4, UAS-GFP). Gal4
activates GFP (green) and FLP recombinase expression, which then removes the ‘FLP-out’ cassette such that the constitutive actin5C promoter
then drives lacZ expression (red) permanently within all subsequent daughter cells. (M) Cortical zone cells are derived from dome-gal4-expressing
cells. The dome-gal4 reporter causes cortical zone (CZ) cells in the third instar lymph gland to be permanently marked with $-gal expression (red)
despite the lack of dome-gal4 expression (as assessed by GFP) in this zone. (N) As a positive control, third instar lymph gland cells were found to
be permanently marked by $-gal expression (red) because of twist-gal4 activation in the embryonic mesoderm, from which the lymph gland is
derived. No GFP expression is detectable, indicating that twist-gal4 is no longer expressed in the third larval instar. (O) As a negative control, we
show that cells of the PSC do not contribute to cortical zone cells. Lineage tracing using Serrate-gal4 revealed that PSC cells remain few in number
and do not give rise to cortical zone cells. The majority of the Serrate-expressing cells appear yellow because of simultaneous expression of GFP









dissect and stain, were examined for the expression of
hematopoietic markers. As expected, Srp and Odd are
expressed throughout the lymph gland during the second instar
(Fig. 1C,D) as they are in the late embryo and third instar
lymph gland (Fig. 1A,B,E). Likewise, the hemocyte-specific
marker Hemese is expressed throughout the lymph gland at this
stage (Fig. 5A), although it is not present in the embryonic
lymph gland (not shown).
To determine whether the cortical zone is already formed or
forming in second instar lymph glands, we examined the
expression of various maturation markers in a pair-wise
manner to establish their temporal order. Of the markers
examined, we found that hml-gal4 and Pxn are the earliest to
be expressed. The majority of maturing cells were found to be
double-positive for hml-gal4 and Pxn expression, although a
few cells were found to express either hml-gal4 or Pxn alone
(Fig. 5B). This indicates that the expression of these markers
is initiated at approximately the same time, although probably
independently, during lymph gland development. The marker
Cg-gal4 is next to be expressed as it was found among a
subpopulation of Pxn-expressing cells (Fig. 5C). Finally, P1
antigen expression is initiated late, usually in the early third
instar (Fig. 5D). Interestingly, the early expression of each of
these maturation markers is restricted to the periphery of the
primary lymph gland lobe, indicating that the cortical zone
begins to form in this position in the second instar. Whenever
possible, each genetic marker was directly compared with
other pertinent markers in double-labeling experiments, except
in cases such as the comparison of two different gal4 reporter
lines or when available antibodies were generated in the same
animal. In such cases, the relationship between the two
markers, for example dome-gal4 and hml-gal4, was inferred
from independent comparison with a third marker such as Pxn.
By studying the temporal sequence of expression of
hemocyte-specific markers, one can describe stages in the
maturation of a hemocyte. As an example, the maturation steps
of a typical plasmatocyte are indicated in Fig. 5E. It should be
noted, however, that not all hemocytes of a particular lineage
are identical. For example, in the late third instar lymph gland,
the large majority of mature plasmatocytes (~80%) expresses
both Pxn and hml-gal4, but the remainder expresses only Pxn
(~15%) or hml-gal4 (~5%) alone. Thus, while plasmatocytes
as a group can be characterized by the expression of
representative markers (shown in Fig. 5E), populations
expressing subsets of these markers indeed exist. It remains
unclear at this time whether this heterogeneity in the hemocyte
population is reflective of specific functional differences.
In the third instar, Pxn is a prototypical hemocyte maturation
marker, while immature cells of the medullary zone express
dome-gal4. Comparing the expression of these two markers in
the second instar revealed an interesting developmental
progression. As mentioned above, a group of cells along the
peripheral edge of these early lymph glands already express
Pxn. These developing hemocytes downregulate the expression
of dome-gal4 (Fig. 5F,F%), as they do in the third instar. Next
to these developing hemocytes is a group of cells that expresses
dome-gal4 but not Pxn; these cells are most similar to
medullary zone cells of the third instar and are therefore
prohemocytes. Interestingly, there also exists a group of cells
in the second instar that expresses neither Pxn nor dome-gal4.
This population is most easily seen in the medial parts of the
gland, close to the centrally placed dorsal vessel (Fig. 5F%).
These cells resemble earlier precursors in the embryo, except
they express the marker Hemese (Fig. 5G). We call these cells
pre-prohemocytes. Our interpretation of the expression data is
that pre-prohemocytes upregulate dome-gal4 to become
prohemocytes. As prohemocytes begin to mature into
hemocytes, dome-gal4 expression is downregulated, while the
expression of maturation markers is initiated. The prohemocyte
and hemocyte populations continue to be represented in the
third instar as components of the medullary and cortical zones,
respectively.
The cells of the PSC are already distinguishable in the late
embryo by their expression of collier (Crozatier et al., 2004).
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Fig. 6. Role of Pvr in plasmatocyte differentiation. (A-E%) Pvr–/Pvr– mutant clones marked by the absence of GFP (A-E, green) expression. To-
pro-3 marks all nuclei (blue). Representative clones are outlined and analyzed for marker expression in A%-E%. P1 antigen (A,A%, red) and Pxn
(B,B%, red) are missing in Pvr–/Pvr– clones, but Hemese (C,C%, red) and Lz (D,D%, red) expression remain unchanged. TUNEL (E,E%, red)
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We found that the canonical PSC marker Ser-lacZ is not
expressed in the embryonic lymph gland (not shown) and is
only expressed in a small number of cells in the second instar
(Fig. 5H). This relatively late onset of expression is consistent
with collier acting genetically upstream of Ser (Crozatier et al.,
2004). Another finding was that the earliest expression of
upd3-gal4 parallels the expression of Ser-lacZ and is restricted
to the PSC region (Fig. 5I,J). Finally, Pvr and dome-gal4 are
excluded from the PSC in the second instar (Fig. 5H,K,K%),
similar to that seen in the third instar.
To determine whether maturing cortical zone cells are
indeed derived from medullary zone prohemocytes, a lineage-
tracing experiment was performed in which dome-gal4 was
used to initiate the permanent marking of all daughter cell
lineages (Fig. 5L). In this system, the dome-gal4 reporter
expresses both UAS-GFP and UAS-FLP. The FLP
recombinase excises an intervening FRT-flanked ‘STOP
cassette’, allowing constitutive expression of lacZ under the
control of the actin5C promoter (Struhl and Basler, 1993). At
any developmental time point, GFP is expressed in cells where
dome-gal4 is active, while lacZ is expressed in all subsequent
daughter cells regardless of whether they continue to express
dome-gal4. In this experiment (Fig. 5M), cortical zone cells
are permanently marked with $-galactosidase despite not
expressing dome-gal4 (as assessed by GFP), indicating that
these cells are derived from a dome-gal4-positive precursor.
This result is consistent with and further supports our
independent marker analysis that showed that dome-gal4-
positive prohemocytes downregulate dome-gal4 expression as
they initiate expression of maturation markers representative of
cortical zone cells. As controls to the above experiment, we
determined the expression patterns of two other gal4 lines,
twist-gal4 and Serrate-gal4. The reporter twist-gal4 is
expressed throughout the embryonic mesoderm from which the
lymph gland is derived. Accordingly, the entire lymph gland is
permanently marked by $-galactosidase (Fig. 5N) despite a
lack of twist-gal4 expression (GFP) in the third instar lymph
gland. Analysis of Ser-gal4 revealed that PSC cells remain a
distinct population of signaling cells that do not contribute to
the cortical zone (Fig. 5O).
Role of Pvr in hemocyte maturation
Genetic manipulation of Pvr function provided valuable insight
into its involvement in the regulation of temporal events of
lymph gland development. To analyze Pvr function, FLP/FRT-
based Pvr-mutant clones were generated in the lymph gland
early in the first instar and then examined during the third instar
for the expression of maturation markers. We found that loss
of Pvr function abolishes P1 antigen and Pxn expression (Fig.
6A,A%,B,B%), but not Hemese expression (Fig. 6C,C%). The
crystal cell markers Lz (Fig. 6D,D%) and ProPOA1 (not shown)
are also expressed normally in Pvr-mutant clones, consistent
with the observation that mature crystal cells lack or
downregulate Pvr (not shown). The fact that Pvr-mutant cells
express Hemese and can differentiate into crystal cells suggests
that Pvr specifically controls plasmatocyte differentiation. Pvr-
mutant cells do not become TUNEL positive (Fig. 6E,E%) but
do express the hemocyte marker Hemese and can differentiate
into crystal cells, all suggesting that the observed block in
plasmatocyte differentiation within the mutant clone is not due
to cell death. Additionally, Pvr-mutant clones were large (Fig.
6) and not significantly different in size from their wild-type
Fig. 7. Proliferation profile of the lymph gland. (A) Second instar primary lobe stained for BrdU incorporation. A single confocal section from
the middle of the lymph gland shows BrdU (red) incorporation in randomly positioned cells. (B,B%) Third instar primary lobe stained for BrdU
incorporation. A single confocal section from the middle of the lymph gland shows that BrdU+ cells (red) are restricted to the cortical zone
marked by Pxn expression (B%, green). (C) Cells incorporating BrdU (red) are excluded from the medullary zone marked by dome-gal4/UAS-
GFP (green). (D) Quantitation of data represented in C. Twelve third instar lymph gland lobes were counted. The y-axis represents the
percentage of total BrdU-positive cells. (E) In secondary lobes of the third instar lymph gland, BrdU+ cells (red) are randomly distributed. To-
pro-3 (blue) marks nuclei. Scale bars: 10 µm. (F) Three phases of proliferation in lymph gland development. Phase 1: growth phase. Lymph
gland cells expand in number from the embryonic stage through the second instar (left panel). Cells in the secondary lobes of the third instar
also belong to this phase. Phase 2: quiescence phase. This comprises the prohemocyte population of the third instar medullary zone. Cells of the









twin spots (not shown). Thus, the primary role of Pvr is not in
the control of cell proliferation. Targeting Pvr by RNA
interference (RNAi) revealed the same phenotypic features (not
shown), confirming that Pvr controls the transition of Hemese-
positive cells to plasmatocyte fate.
Proliferation profile of the developing lymph gland
We monitored entry into S phase using BrdU incorporation and
identified distinct proliferative phases that occur during lymph
gland hematopoiesis. In the second instar, proliferating cells
are evenly distributed throughout the lymph gland (Fig. 7A).
By the third instar, however, the distribution of proliferating
cells is no longer uniform; S-phase cells are largely restricted
to the cortical zone (Fig. 7B-D). This is particularly evident
when BrdU-labeled lymph glands are co-stained with Pxn (Fig.
7B%). Medullary zone cells, which can be identified by the
expression of dome-gal4, rarely incorporate BrdU (Fig. 7C,D).
Therefore, the rapidly cycling prohemocytes of the second
instar lymph gland quiesce as they populate the medullary zone
of the third instar. As prohemocytes transition into hemocyte
fates in the cortical zone, they once again begin to expand in
number. This is supported by the observation that the
medullary zone in white pre-pupae does not appear
diminished in size (not shown), suggesting that the
primary mechanism for the expansion of the cortical
zone prior to this stage is through cell division within
the zone. Proliferating cells in the secondary lobes
continue to be distributed uniformly in the third
instar (Fig. 7E), suggesting that secondary-lobe
prohemocytes do not reach a state of quiescence as
do the cells of the medullary zone. These results
indicate that cells of the lymph gland go through
distinct proliferative phases as hematopoietic
development proceeds (Fig. 7F, also see discussion
below).
Discussion
The Drosophila lymph gland has long been known to be a
hematopoietic organ but was largely perceived as a mass of
cells that differentiate into the major hemocyte types. The
mechanisms by which this occurs were relatively
uncharacterized and the structural features of the lymph gland
had not been correlated with the cellular events underlying
hematopoiesis. We set out to systematically describe lymph
gland development in the context of hemocyte maturation.
Using genetic markers known to be expressed by
hematopoietic cells as a starting point, we examined when and
where these markers are expressed in the lymph gland.
Furthermore, we identified and defined structural features of
the lymph gland not previously described and then determined
how these features correlate with hemocyte maturation and
patterns of cell proliferation.
Our analysis of the lymph gland revealed three key features
that arise during development. The first feature is the presence
of three distinct zones in the primary lymph gland lobe of third
instar larvae. Two of these zones, which we term the cortical
and medullary zones, exhibit structural characteristics that
make them morphologically distinct. These zones, as well as
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Fig. 8. Schematic diagram of hemocyte maturation in the
lymph gland. (A) The earliest lymph gland cells, the
hemocyte precursors (HP), express Srp (S+) and Odd
(O+). As these cells transition into pre-prohemocyte
(PPH) fate, they initiate the expression of Hemese (H+)
and Pvr (Pv+). Prohemocytes (PH) initiate dome-gal4
(dg4+) expression. Maturation to the various hemocyte (H)
fates requires downregulation of dome-gal4 (dg4–),
upregulation of different maturation markers (M+) and the
involvement of the indicated signaling pathways.
(B) Spatial and temporal sequence of hemocyte
development in the lymph gland (see text for details). The
PSC cells are marked by Collier (C+) and Serrate (Ser+)
expression. Ubiquitous cell markers such as Srp, Odd, Pvr
and Hemese are expressed in all the lymph gland cells
marked by the nuclear marker To-pro-3, thus they are
expressed in all the cell types and the zones. Mature
hemocytes markers such as Pxn, P1 and Lz were
compared with dome-gal4 expression. Lamellocyte
marker msn-lacZ was compared with G147. All the
markers used in the diagram except Collier were directly
compared with Ser-lacZ. PM, plasmatocyte; CC, crystal
cell; LM, lamellocyte; CZ, cortical zone; MZ, medullary
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the third zone, the PSC, are also distinguishable by the
expression of specific markers. The second key feature is the
finding that cells expressing maturation markers such as Lz,
ProPOA1, Pxn, hml-gal4 and Cg-gal4 are restricted to the
cortical zone. The medullary zone is consistently devoid of
maturation marker expression and is therefore defined as a
region composed of immature hemocytes (prohemocytes). The
finding of different developmental populations within the
lymph gland (prohemoctyes and their derived hemocytes) is
similar to the situation in vertebrates where it is known that
hematopoietic stem cells and other blood precursors give rise
to various mature cell types. Additionally, Drosophila
hemocyte maturation is akin to the progressive maturation of
myeloid and lymphoid lineages in vertebrate hematopoiesis.
The third key feature of lymph gland hematopoiesis is the
dynamic pattern of cellular proliferation observed in the third
instar. At this stage, the vast majority of S-phase cells in the
primary lobe are located in the cortical zone, suggesting
a strong correlation between proliferation and hemocyte
differentiation. Compared with earlier developmental stages,
cell proliferation in the medullary zone actually decreases by
the late third instar, suggesting that these cells have entered a
quiescent state. Thus, proliferation in the lymph gland appears
to be regulated such that growth, quiescence and expansion
phases are evident throughout its development (Fig. 7F).
Drosophila blood cell precursors, prohemocytes and
maturing hemocytes each exhibit extensive phases of
proliferation. The competence of these cells to proliferate
seems to be a distinct cellular characteristic that is
superimposed upon the intrinsic maturation program. Based on
the patterns of BrdU incorporation in developing primary and
secondary lymph gland lobes, it is possible to envision at least
two levels of proliferation control during hematopoiesis. We
propose that the widespread cell proliferation observed in
second instar lymph glands and in secondary lobes of third
instar lymph glands occurs in response to a growth requirement
that provides a sufficient number of prohemocytes for
subsequent differentiation. The mechanisms promoting
differentiation in the cortical zone also trigger cell
proliferation, which accounts for the observed BrdU
incorporation in this zone and serves to expand the effector
hemocyte population. The quiescent cells of the medullary
zone represent a pluripotent precursor population because they,
similar to vertebrate hematopoietic precursors, rarely divide
and give rise to multiple lineages and cell types.
Based on the analysis described above, we can propose a
model by which hemocytes mature in the lymph gland (Fig. 8).
Hematopoietic precursors that populate the early lymph gland
are first distinguishable as Srp+, Odd+ (S+O+, Fig. 8A) cells.
These will eventually give rise to a primary lymph gland lobe
where the steps of hemocyte maturation are most apparent.
During the first or early second instar, these S+O+ cells begin
to express the hemocyte-specific marker Hemese (He) and the
tyrosine kinase receptor Pvr. Such cells can be called pre-
prohemocytes and, in the second instar, cells expressing only
these markers occupy a narrow region near the dorsal vessel.
Subsequently, a subset of these Srp+, Odd+, He+, Pvr+
(S+O+H+Pv+) pre-prohemocytes initiate the expression of
dome-gal4 (dg4), thereby maturing into prohemocytes. The
prohemocyte population (S+O+H+Pv+dg4+) can be subdivided
into two developmental stages. Stage 1 prohemocytes, which
are abundantly seen in the second instar, are proliferative,
whereas stage 2 prohemocytes, exemplified by the cells of the
medullary zone, are quiescent. As development continues,
prohemocytes begin to downregulate dome-gal4 and express
maturation markers (M; becoming S+O+H+Pv+dg4lowM+).
Eventually, dome-gal4 expression is lost entirely in these cells
(becoming S+O+H+Pv+dg4–M+), found generally in the cortical
zone. Thus, the maturing hemocytes of the cortical zone are
derived from prohemocytes previously belonging to the
medullary zone. This is supported by lineage-tracing
experiments that showed cells expressing medullary zone
markers can indeed give rise to cells of the cortical zone. In
turn, the medullary zone is derived from the earlier, pre-
prohemocytes. Early cortical zone cells continue to express
successive maturation markers (M) as they proceed towards
terminal differentiation (Fig. 8B). Depending on the hemocyte
type, examples of expressed maturation markers are Pxn, P1,
Lz, L1, msn-lacZ, etc. Our studies have shown that
differentiation of the plasmatocyte lineage requires Pvr, while
previous work has shown that the Notch pathway is crucial for
the crystal cell fate (Duvic et al., 2002; Lebestky et al., 2003).
Both the JAK/STAT and Notch pathways have been implicated
in lamellocyte production (Duvic et al., 2002; Sorrentino et al.,
2004).
Previous investigations have demonstrated that similar
transcription factors and signal transduction pathways are used
in the specification of blood lineages in both vertebrates and
Drosophila. Given this relationship, Drosophila represents a
powerful system for identifying genes crucial to the
hematopoietic process that are conserved in the vertebrate
system. The work presented here provides an analysis of
hematopoietic development in the Drosophila lymph gland that
not only identifies stage-specific markers, but also reveals
developmental mechanisms underlying hemocyte specification
and maturation. The prohemocyte population in Drosophila
becomes mitotically quiescent, much as their multipotent
precursor counterparts in mammalian systems. These
conserved mechanisms further establish Drosophila as an
excellent genetic model for the study of hematopoiesis.
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